A patient-derived, autologous component-integrated biomimetic hydrogel system for lung cancer organoid culture and recapitulation of immunotherapy response
BACKGROUND: Matrigel-based culture of patient-derived lung cancer organoids (LCOs) is limited by undefined composition, batch-to-batch variability, and immunogenicity, which compromise experimental reproducibility and drug response readouts. METHODS: We developed an autologous component-integrated hydrogel by incorporating patient-derived decellularized lung fiber fragments (1.25 μm diameter; 52.5 μm length) and optimized autologous plasma (56 °C, 30 min; 8,000×g, 5 min; 5% v/v) into a porous gelatin methacryloyl (GelMA) network. Five formulations-GelMA, GelMA+ fiber, GelMA + plasma, MC-GelMA (fibers + plasma) and Matrigel-were compared to dissect component contributions. LCOs were established from 8 patients, and PBMC co-culture experiments were performed with 3 samples (1 PD-L1-positive, 2 PD-L1-negative). RESULTS: MC-GelMA exhibited uniform porosity and a Young's modulus of 15.67 ± 0.86 kPa, closely matching native lung tumor tissue. Compared with Matrigel, LCOs cultured in MC-GelMA exhibited in vivo-like morphology, enhanced viability and metabolic activity, and preservation of key histological and genomic features.The platform supported stable long-term culture through passage 9 with maintained drug sensitivity. Component analysis revealed that fibers mainly provided structural and mechanical cues, while plasma supplied biochemical signals; their combination synergistically enhanced organoid growth and immune cell infiltration. In co-culture, MC-GelMA recapitulated anti-PD-L1 responses: PD-L1-positive organoids showed increased LDH release, whereas PD-L1-negative organoids did not respond. CONCLUSION: In conclusion, this autologous component-integrated biomimetic hydrogel serves as a highly reproducible biofabrication platform for stable LCO culture and reliable recapitulation of patient-specific immunotherapy response patterns. Further validation in larger cohorts is warranted to establish its predictive potential for clinical immunotherapy outcomes.
Authors
- 云舞扬 (ORCID: https://orcid.org/0009-0003-2109-6128)
- Huifeng Liu
- Li Xiao (ORCID: https://orcid.org/0000-0002-5488-5583)
- Yuyu Li (ORCID: https://orcid.org/0000-0003-4672-295X)
- Wen Chen (ORCID: https://orcid.org/0009-0001-7707-5751)
- Jing Yuan
Institutions
- Chinese PLA General Hospital (CN)
- Kailuan General Hospital (CN)
Publication Details
- Journal
- Biofabrication
- Published
- 2026-11-12
- DOI
- https://doi.org/10.1088/1758-5090/aec19a
- Primary Topic
- Hydrogels: synthesis, properties, applications
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China